Excess Mortality from Mental, Neurological, and Substance Use Disorders in the Global Burden of Disease Study 2010
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Groups countries into 21 regions and seven super-regions based on geographic proximity and levels of child and adult mortality, with further groupings into developed and developing categories, to explore the cause-specific and excess mortality correlated with individual mental, neurological, and substance use (MNS) disorders. The Global Burden of Disease Study 2010 (GBD 2010) results, using comparative risk assessments (CRAs), reveal elevated rates of excess mortality across most mental and substance use disorders. Mental disorders have also been linked to higher rates of death caused by cardiovascular disease, stroke, diabetes mellitus, respiratory diseases, and some cancers, though the relationship between mental disorders and a specific physical disease, leading to premature death, is complex. Mental disorders are associated with poorer clinical management of comorbid conditions, as physical complaints may be overlooked and attributed to psychological and psychiatric factors. Prevention of excess mortality in people with these disorders should be considered a high priority in the reform of health systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citationFerrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
Self-citationWalker, E. R., McGee, R. E., & Druss, B. G. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2502 · Cited by 2,976
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Risks of all-cause and suicide mortality in mental disorders: a meta-review
Chesney, E., Goodwin, G. M., & Fazel, S. (2014) · World Psychiatry · doi:10.1002/wps.20128 · Cited by 2,115
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
The Clinical Course of Advanced Dementia.
Mitchell, S. L., Teno, J. M., Kiely, D. K., Shaffer, M. L., Jones, R. N., Prigerson, H. G., Volicer, L., Givens, J. L., & Hamel, M. B. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902234 · Cited by 1,618
The relation between different dimensions of alcohol consumption and burden of disease: an overview
Rehm, J., Baliunas, D., Borges, G. L. G., Graham, K., Irving, H., Kehoe, T., Parry, C. D., Patra, J., Popova, S., Poznyak, V., et al. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02899.x · Cited by 1,174
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
Salomon, J. A., Wang, H., Freeman, M. K., Vos, T., Flaxman, A. D., Lopez, A. D., & Murray, C. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61690-0 · Cited by 1,116
Self-citation
Cited by
What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?
Correll, C. U., Rubio, J. M., & Kane, J. M. (2018) · World Psychiatry · doi:10.1002/wps.20516 · Cited by 324
Evidence on Virtual Reality-Based Therapies for Psychiatric Disorders: Meta-Review of Meta-Analyses
Dellazizzo, L., Potvin, S., Luigi, M., & Dumais, A. (2020) · Journal of Medical Internet Research · doi:10.2196/20889 · Cited by 135
Moser, D. A., Glaus, J., Frangou, S., & Schechter, D. S. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2020.56 · Cited by 88
Santini, Z. I., Ekholm, O., Koyanagi, A., Stewart-Brown, S., Meilstrup, C., Nielsen, L., Fusar-Poli, P., Koushede, V., & Thygesen, L. C. (2022) · Mental Health & Prevention · doi:10.1016/j.mhp.2022.200233 · Cited by 40
Metadata
- Authors
- Charlson, F. J., Baxter, A. J., Dua, T., Degenhardt, L., Whiteford, H. A., & Vos, T.
- Venue
- Disease Control Priorities, Third Edition (Volume 4): Mental, Neurological, and Substance Use Disorders
- Publisher
- The World Bank
- Published
- 2016-03-10
- Pages
- 41-65
- OpenAlex
- W4239663142
- Cited by
- 55
- References
- 36
- FWCI
- 31.78
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Excess Mortality from Mental, Neurological, and Substance Use Disorders in the Global Burden of Disease Study 2010. https://app.cochat.ai/papers/10.1596/978-1-4648-0426-7_ch3
- The paper
- Charlson, F. J., Baxter, A. J., Dua, T., Degenhardt, L., Whiteford, H. A., & Vos, T. (2016). Excess Mortality from Mental, Neurological, and Substance Use Disorders in the Global Burden of Disease Study 2010. Disease Control Priorities, Third Edition (Volume 4): Mental, Neurological, and Substance Use Disorders. https://doi.org/10.1596/978-1-4648-0426-7_ch3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.